Skip to main content

Table 1 Factors associated with smoking status in a cross-sectional study, College Park, MD, n = 40

From: Association between cigarette smoking and the vaginal microbiota: a pilot study

 

Non-smokers*

Smokers

P value**

 

n

%

n

%

 

Vaginal community state type (CST)§

    

0.04

  CST I, L. crispatus-dominated

13

65.0

6

30.0

 

  CST III, L. iners-dominated

4

20.0

4

20.0

 

  CST IV, Lactobacillus-deficient

3

15.0

10

50.0

 

Nugent Gram stain score

    

0.02

  0-3

17

85.0

10

50.0

 

  4-6

2

10.0

2

10.0

 

  7-10

1

5.0

8

40.0

 

Vaginal pH†

    

0.13

  <=4

10

50.0

4

20.0

 

  4.1-5.5

1

5.0

2

10.0

 

  4.6-5.0

4

20.0

3

15.0

 

  > = 5.1

5

25.0

11

55.0

 

Age

    

<0.01

  18-28

17

85.0

5

25.0

 

  29-39

1

5.0

7

35.0

 

  40-45

2

10.0

8

40.0

 

Ethnicity

    

0.16

  African-American

5

25.0

10

50.0

 

  Asian/Pacific islander

3

15.0

1

5.0

 

  Hispanic

3

15.0

0

0.0

 

  Multi-racial

1

5.0

3

15.0

 

  White

8

40.0

6

30.0

 

Marital status

    

0.09

  Never married

17

85.0

10

50.0

 

  Married

2

10.0

4

20.0

 

  Separated, divorced, widowed

1

5.0

5

25.0

 

  Other

0

0.0

1

5.0

 

Education, years

    

0.06

  12

0

0.0

5

25.0

 

  13-16

18

90.0

13

65.0

 

  > = 17

2

10.0

2

10.0

 

Biomarkers of smoking

     

  Cotinine, ng/ml

    

<0.01

  0-10

1

5.0

0

0.0

 

  11-30

17

85.0

0

0.0

 

  31-100

2

10.0

0

0.0

 

  101-200

-

-

-

-

 

  201-500

-

-

-

-

 

  501-1000

0

0.0

2

10.0

 

  >1000

0

0.0

18

90.0

 

  Carbon monoxide exhalation, ppm

    

<0.01

  0-7

20

100.0

0

0.0

 

  8-10

0

0.0

11

55.0

 

  11+

0

0.0

9

45.0

 

Self-reported factors

     

  Number of cigarettes per day

    

<0.01

  None

20

100.0

0

0.0

 

  1-10

0

0.0

11

55.0

 

  11-20

0

0.0

9

45.0

 

  Symptoms in 24 hours prior to visit

     

  Odor

5

25.0

3

15.0

0.70

  Irritation

0

0.0

0

0.0

-

  Itching

0

0.0

0

0.0

-

  Burning

0

0.0

0

0.0

-

  Pain on urination

0

0.0

0

0.0

-

  Discharge

5

25.0

4

20.0

>0.99

  Diagnoses in the prior 2 months

     

  None

19

95.0

17

94.4

0.73

  Bacterial vaginosis

0

0.0

1

5.6

 

  Trichomonas vaginalis and Chlamydia trachomatis

1

5.0

0

0.0

 

  Number of male sex partners in the prior 2 months

    

0.63

  0

5

26.3

4

21.1

 

  1

11

57.9

14

73.7

 

  2-3

3

15.8

1

5.3

 

  Number of female sex partners in the prior 2 months

    

0.73

  0

16

94.1

14

93.3

 

  1

1

5.9

1

6.7

 

  Lifetime number of sex partners

    

<0.01

  0-4

8

40

2

11.1

 

  5-7

9

45

1

5.6

 

  8+

3

15

15

83.3

 

  Hormonal contraception (HC)

    

0.19

  Other, non-HC

6

33.3

8

57.1

 

  Oral contraceptive pill

11

61.1

4

28.6

 

  Injectable

1

5.6

2

14.3

 

  Frequency of vaginal douching in prior 2 months

    

0.06

  None

18

90.0

12

63.2

 

  Every now and then

0

0.0

1

5.3

 

  1–2 times per month

1

5.0

5

26.3

 

  1 time per week

1

5.0

0

0.0

 

  More than one time per week

0

0.0

1

5.3

 

  Sexual activity in prior 24 hours

    

0.34

  No vaginal intercourse

15

75.0

10

50.0

 

  Vaginal intercourse without a condom

3

15.0

6

30.0

 

  Vaginal intercourse with a condom

2

10.0

4

20.0

 

  Menstrual hygiene in prior 24 hours

    

>0.99

  Sanitary napkin, no tampon

11

57.9

11

64.7

 

  Sanitary napkin only

2

10.5

1

5.9

 

  Tampon only

4

21.1

4

23.5

 

  Tampon and sanitary napkin

2

10.5

1

5.9

 
  1. §CST defined by Ravel et al.44
  2. *Non-smoker defined by self-report and 0–200 ng/ml on saliva cotinine test (NicAlert®) and 0–7 ppm on carbon monoxide exhalation (ppm), Bedfont Micro Smokerlyzer®.
  3. **P- values determined by Fisher's exact test.
  4. †CarePlan® VpH Test Glove.